Citigroup’s Aratana Therapeutics, Inc. PETX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-15,217
| Closed | -$78K | – | 7958 |
|
|
2019
Q2 | $78K | Buy |
15,217
+1,946
| +15% | +$8.75K | ﹤0.01% | 6097 |
|
|
2019
Q1 | $48K | Buy |
13,271
+1,145
| +9% | +$4.96K | ﹤0.01% | 6383 |
|
|
2018
Q4 | $74K | Buy |
12,126
+53
| +0.4% | +$323 | ﹤0.01% | 5911 |
|
|
2018
Q3 | $70K | Buy |
12,073
+11,173
| +1,241% | +$55.8K | ﹤0.01% | 6238 |
|
|
2018
Q2 | $4K | Sell |
900
-5,398
| -86% | -$27.2K | ﹤0.01% | 7405 |
|
|
2018
Q1 | $27K | Buy |
6,298
+5,045
| +403% | +$22.5K | ﹤0.01% | 6584 |
|
|
2017
Q4 | $7K | Sell |
1,253
-1,050
| -46% | -$6.42K | ﹤0.01% | 7167 |
|
|
2017
Q3 | $14K | Buy |
2,303
+1,301
| +130% | +$8.23K | ﹤0.01% | 6595 |
|
|
2017
Q2 | $7K | Sell |
1,002
-6,069
| -86% | -$37.3K | ﹤0.01% | 6666 |
|
|
2017
Q1 | $37K | Sell |
7,071
-38,186
| -84% | -$258K | ﹤0.01% | 5903 |
|
|
2016
Q4 | $325K | Buy |
45,257
+28,996
| +178% | +$234K | ﹤0.01% | 4830 |
|
|
2016
Q3 | $152K | Buy |
16,261
+9,624
| +145% | +$79.9K | ﹤0.01% | 4888 |
|
|
2016
Q2 | $42K | Sell |
6,637
-24,444
| -79% | -$157K | ﹤0.01% | 5680 |
|
|
2016
Q1 | $172K | Buy |
31,081
+22,677
| +270% | +$85.3K | ﹤0.01% | 5232 |
|
|
2015
Q4 | $48K | Buy |
8,404
+6,308
| +301% | +$41.7K | ﹤0.01% | 5972 |
|
|
2015
Q3 | $18K | Sell |
2,096
-2,532
| -55% | -$42.8K | ﹤0.01% | 6118 |
|
|
2015
Q2 | $70K | Sell |
4,628
-1,589
| -26% | -$22.9K | ﹤0.01% | 5274 |
|
|
2015
Q1 | $100K | Sell |
6,217
-6,120
| -50% | -$109K | ﹤0.01% | 5028 |
|
|
2014
Q4 | $220K | Buy |
12,337
+10,775
| +690% | +$134K | ﹤0.01% | 4605 |
|
|
2014
Q3 | $16K | Buy |
1,562
+1,356
| +658% | +$16.4K | ﹤0.01% | 6038 |
|
|
2014
Q2 | $3K | Sell |
206
-1,252
| -86% | -$17.7K | ﹤0.01% | 6677 |
|
|
2014
Q1 | $27K | Sell |
1,458
-692
| -32% | -$13.9K | ﹤0.01% | 5872 |
|
|
2013
Q4 | $41K | Buy |
+2,150
| New | +$43.6K | ﹤0.01% | 5818 |
|
Other funds holding PETX
Citigroup's PETX Position: Q3 2019 in Review
Citigroup sold out of Aratana Therapeutics, Inc. (PETX) in Q3 2019, closing a stake of 15,217 shares — an estimated $78K sold.
Citigroup first reported a position in PETX in Q4 2013 and held it in 23 quarters. The position peaked at $325K in Q4 2016. 2 funds tracked by Wall St. Rank hold PETX as of Q3 2019.
- Citigroup reported no remaining Aratana Therapeutics, Inc. position as of Q3 2019 after selling out during the quarter.
- Citigroup sold 15,217 Aratana Therapeutics, Inc. shares in Q3 2019, an estimated $78K.
- Citigroup first reported a position in Aratana Therapeutics, Inc. in Q4 2013 and held it in 23 quarters.
- Citigroup's Aratana Therapeutics, Inc. position peaked at $325K in Q4 2016.
- 2 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q3 2019.
Based on Citigroup's 13F filing for Q3 2019, filed 8 Nov 2019.